CHU
Clermont-Ferrand, 63000, France
NCT Number: NCT07746193
France is among the countries with one of the highest suicide rates in the world, far ahead of its neighboring nations [Wasserman et al., 2012]. Suicide represents the second leading cause of death among 15-24-year-olds, just after road accidents, and the leading cause of death among 25-34-year-olds. In this context, a better utilization of all components of the healthcare system seems highly desirable, particularly through greater involvement of community psychiatrists in suicide prevention strategies. Approximately 25% of individuals who die by suicide have consulted a psychiatrist in the month preceding their death [Luoma et al., 2002], yet few data are available on this topic, especially regarding consultations with community psychiatrists outside of hospital settings.
Study objectives Main objective To assess the prevalence of suicidal risk during the 15 days preceding an outpatient psychiatric consultation in the Clermont-Ferrand area.
Main secondary objectives
* To describe the recruited population and potentially associated factors (age, sex, etc.). * To assess the psychological pain of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst. * To assess the self-esteem of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Clermont-Ferrand, 63000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1
aRSD scale score from 0 to 10 (worse is 10)
Time frame: Day 1
Self-Esteem Scale (SES) score. From 0 to 24. 24 is the worste outcome
Time frame: Day 1
Visual Analog Scale (VAS) score for psychological pain. from 0 to 10. 10 is the worse outcome.
University Hospital, Clermont-Ferrand
Other
Acronym: RSCP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740356
Mental Disorders, Psychiatric Disorder
Clermont-Ferrand, France
View Trial DetailsNCT06014164
Mental Disorders, Psychiatric Disorder
Toulouse, France
View Trial DetailsNCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05680727
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial Details